| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Arp2/3 complex binding | 2.94e-04 | 16 | 32 | 2 | GO:0071933 | |
| GeneOntologyMolecularFunction | protein kinase A regulatory subunit binding | 7.29e-04 | 25 | 32 | 2 | GO:0034237 | |
| GeneOntologyMolecularFunction | transcription regulator inhibitor activity | 1.52e-03 | 36 | 32 | 2 | GO:0140416 | |
| GeneOntologyBiologicalProcess | regulation of transcription by RNA polymerase I | 6.33e-05 | 50 | 32 | 3 | GO:0006356 | |
| GeneOntologyBiologicalProcess | positive regulation of Arp2/3 complex-mediated actin nucleation | 6.49e-05 | 8 | 32 | 2 | GO:2000601 | |
| GeneOntologyBiologicalProcess | RNA splicing | 1.07e-04 | 502 | 32 | 6 | GO:0008380 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | 1.23e-04 | 515 | 32 | 6 | GO:0022613 | |
| GeneOntologyBiologicalProcess | positive regulation of actin nucleation | 2.10e-04 | 14 | 32 | 2 | GO:0051127 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 2.10e-04 | 358 | 32 | 5 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 2.10e-04 | 358 | 32 | 5 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 2.21e-04 | 362 | 32 | 5 | GO:0000375 | |
| GeneOntologyBiologicalProcess | transcription by RNA polymerase I | 2.48e-04 | 79 | 32 | 3 | GO:0006360 | |
| GeneOntologyBiologicalProcess | RNA processing | 3.36e-04 | 1500 | 32 | 9 | GO:0006396 | |
| GeneOntologyBiologicalProcess | mitotic chromosome condensation | 3.92e-04 | 19 | 32 | 2 | GO:0007076 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | 5.06e-04 | 670 | 32 | 6 | GO:0120031 | |
| GeneOntologyBiologicalProcess | cell projection assembly | 5.69e-04 | 685 | 32 | 6 | GO:0030031 | |
| GeneOntologyBiologicalProcess | modification of postsynaptic actin cytoskeleton | 6.30e-04 | 24 | 32 | 2 | GO:0098885 | |
| GeneOntologyBiologicalProcess | regulation of Arp2/3 complex-mediated actin nucleation | 1.05e-03 | 31 | 32 | 2 | GO:0034315 | |
| GeneOntologyCellularComponent | U2AF complex | 4.45e-05 | 7 | 31 | 2 | GO:0089701 | |
| GeneOntologyCellularComponent | SCAR complex | 1.39e-04 | 12 | 31 | 2 | GO:0031209 | |
| GeneOntologyCellularComponent | spliceosomal complex | 2.75e-04 | 215 | 31 | 4 | GO:0005681 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 6.99e-04 | 1377 | 31 | 8 | GO:0140513 | |
| GeneOntologyCellularComponent | U12-type spliceosomal complex | 9.02e-04 | 30 | 31 | 2 | GO:0005689 | |
| Domain | SCAR/WAVE_fam | 6.98e-06 | 3 | 29 | 2 | IPR028288 | |
| Domain | WSD | 2.32e-05 | 5 | 29 | 2 | PF15613 | |
| Domain | DDT | 2.32e-05 | 5 | 29 | 2 | SM00571 | |
| Domain | DDT_dom | 2.32e-05 | 5 | 29 | 2 | IPR018501 | |
| Domain | WHIM2_dom | 2.32e-05 | 5 | 29 | 2 | IPR028941 | |
| Domain | DDT | 3.48e-05 | 6 | 29 | 2 | PS50827 | |
| Domain | WH2 | 2.09e-04 | 14 | 29 | 2 | SM00246 | |
| Domain | PHD | 2.11e-04 | 75 | 29 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 2.46e-04 | 79 | 29 | 3 | IPR019787 | |
| Domain | WH2 | 2.76e-04 | 16 | 29 | 2 | PF02205 | |
| Domain | PHD | 3.49e-04 | 89 | 29 | 3 | SM00249 | |
| Domain | Znf_PHD | 3.73e-04 | 91 | 29 | 3 | IPR001965 | |
| Domain | ZF_PHD_2 | 4.23e-04 | 95 | 29 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 4.36e-04 | 96 | 29 | 3 | PS01359 | |
| Domain | WH2_dom | 4.80e-04 | 21 | 29 | 2 | IPR003124 | |
| Domain | WH2 | 6.29e-04 | 24 | 29 | 2 | PS51082 | |
| Domain | Bromodomain_CS | 7.39e-04 | 26 | 29 | 2 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 1.50e-03 | 37 | 29 | 2 | PS00633 | |
| Domain | Znf_FYVE_PHD | 1.50e-03 | 147 | 29 | 3 | IPR011011 | |
| Domain | Bromodomain | 1.58e-03 | 38 | 29 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 1.84e-03 | 41 | 29 | 2 | PS50014 | |
| Domain | BROMO | 1.93e-03 | 42 | 29 | 2 | SM00297 | |
| Domain | Bromodomain | 1.93e-03 | 42 | 29 | 2 | IPR001487 | |
| Domain | - | 1.93e-03 | 42 | 29 | 2 | 1.20.920.10 | |
| Domain | Zinc_finger_PHD-type_CS | 4.56e-03 | 65 | 29 | 2 | IPR019786 | |
| Pathway | REACTOME_MRNA_SPLICING | 2.56e-07 | 201 | 20 | 6 | MM15411 | |
| Pathway | REACTOME_MRNA_SPLICING | 3.50e-07 | 212 | 20 | 6 | M14033 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.68e-06 | 277 | 20 | 6 | MM15414 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.90e-06 | 283 | 20 | 6 | M13087 | |
| Pathway | BIOCARTA_ACTINY_PATHWAY | 8.55e-05 | 10 | 20 | 2 | MM1528 | |
| Pathway | BIOCARTA_ACTINY_PATHWAY | 1.25e-04 | 12 | 20 | 2 | M7825 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 1.50e-04 | 612 | 20 | 6 | MM15547 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_TO_RAC_SIGNALING_PATHWAY | 3.58e-04 | 20 | 20 | 2 | M47737 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 3.75e-04 | 724 | 20 | 6 | M16843 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 5.63e-04 | 25 | 20 | 2 | M47716 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGD_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 7.59e-04 | 29 | 20 | 2 | M47717 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 8.12e-04 | 30 | 20 | 2 | M47738 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES | 1.04e-03 | 34 | 20 | 2 | MM15265 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES | 1.17e-03 | 36 | 20 | 2 | M27549 | |
| Pathway | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | 2.07e-03 | 48 | 20 | 2 | MM15410 | |
| Pathway | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | 2.25e-03 | 50 | 20 | 2 | M5583 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 4.73e-03 | 73 | 20 | 2 | M638 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | EIF5B BAZ1B KRI1 BOD1L1 TAF3 LYAR LUC7L3 BAZ2B RSL1D1 PRRC2C NSRP1 ZMAT2 | 2.31e-11 | 954 | 32 | 12 | 36373674 |
| Pubmed | 2.71e-09 | 251 | 32 | 7 | 31076518 | ||
| Pubmed | 1.03e-08 | 483 | 32 | 8 | 36912080 | ||
| Pubmed | CEP350 NUSAP1 KRI1 TBC1D10B UPF3B TAF3 LYAR PDCD7 LUC7L3 RSL1D1 PRRC2C | 2.06e-08 | 1371 | 32 | 11 | 36244648 | |
| Pubmed | The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival. | 4.73e-08 | 220 | 32 | 6 | 31822558 | |
| Pubmed | DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC. | 7.73e-08 | 118 | 32 | 5 | 37105989 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.13e-07 | 934 | 32 | 9 | 33916271 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NUSAP1 EIF5B TBC1D10B UPF3B LYAR LUC7L3 RSL1D1 NSRP1 PPP1R9A | 1.29e-07 | 949 | 32 | 9 | 36574265 |
| Pubmed | 1.56e-07 | 971 | 32 | 9 | 33306668 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 3.28e-07 | 759 | 32 | 8 | 35915203 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 3.89e-07 | 1082 | 32 | 9 | 38697112 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 29512856 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 16190876 | ||
| Pubmed | The Association Between WAVE1 and -3 and the ARP2/3 Complex in PC 3 Cells. | 8.20e-07 | 2 | 32 | 2 | 26977009 | |
| Pubmed | 1.64e-06 | 645 | 32 | 7 | 25281560 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 2.29e-06 | 678 | 32 | 7 | 30209976 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 2.38e-06 | 989 | 32 | 8 | 36424410 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 9732292 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 28589370 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 15280206 | ||
| Pubmed | Characterization of the WAVE1 knock-out mouse: implications for CNS development. | 2.46e-06 | 3 | 32 | 2 | 12716942 | |
| Pubmed | Expression and subcellular localization of WAVE isoforms in the megakaryocyte/platelet lineage. | 2.46e-06 | 3 | 32 | 2 | 15670045 | |
| Pubmed | Genomic organization and expression profile of the human and mouse WAVE gene family. | 2.46e-06 | 3 | 32 | 2 | 12856283 | |
| Pubmed | 3.13e-06 | 451 | 32 | 6 | 30033366 | ||
| Pubmed | 3.18e-06 | 713 | 32 | 7 | 29802200 | ||
| Pubmed | 3.23e-06 | 251 | 32 | 5 | 28077445 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 3.79e-06 | 1425 | 32 | 9 | 30948266 | |
| Pubmed | 3.92e-06 | 469 | 32 | 6 | 27634302 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 17664349 | ||
| Pubmed | Neutrophils establish rapid and robust WAVE complex polarity in an actin-dependent fashion. | 4.92e-06 | 4 | 32 | 2 | 19200726 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 7.16e-06 | 807 | 32 | 7 | 22681889 | |
| Pubmed | 7.28e-06 | 809 | 32 | 7 | 32129710 | ||
| Pubmed | TXLNA enhances TBK1 phosphorylation by suppressing PPM1B recruitment. | 7.83e-06 | 138 | 32 | 4 | 37506885 | |
| Pubmed | FBP11 regulates nuclear localization of N-WASP and inhibits N-WASP-dependent microspike formation. | 8.19e-06 | 5 | 32 | 2 | 14697212 | |
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 10662543 | ||
| Pubmed | WAVE2 is required for directed cell migration and cardiovascular development. | 8.19e-06 | 5 | 32 | 2 | 12879075 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 1.03e-05 | 148 | 32 | 4 | 32538781 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 1.22e-05 | 330 | 32 | 5 | 33301849 | |
| Pubmed | Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study. | 1.23e-05 | 6 | 32 | 2 | 20802025 | |
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 25527710 | ||
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 25745180 | ||
| Pubmed | 1.31e-05 | 335 | 32 | 5 | 15741177 | ||
| Pubmed | 1.61e-05 | 601 | 32 | 6 | 33658012 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.67e-05 | 605 | 32 | 6 | 28977666 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.71e-05 | 608 | 32 | 6 | 36089195 | |
| Pubmed | Interaction of WASP/Scar proteins with actin and vertebrate Arp2/3 complex. | 2.29e-05 | 8 | 32 | 2 | 11146629 | |
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 10381382 | ||
| Pubmed | 2.31e-05 | 641 | 32 | 6 | 36057605 | ||
| Pubmed | 2.58e-05 | 62 | 32 | 3 | 19710015 | ||
| Pubmed | Interactome study suggests multiple cellular functions of hepatoma-derived growth factor (HDGF). | 2.81e-05 | 191 | 32 | 4 | 21907836 | |
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 38981622 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 2.96e-05 | 670 | 32 | 6 | 22990118 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 3.23e-05 | 1415 | 32 | 8 | 28515276 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 3.63e-05 | 695 | 32 | 6 | 23602568 | |
| Pubmed | 3.73e-05 | 417 | 32 | 5 | 36537216 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 3.80e-05 | 701 | 32 | 6 | 30196744 | |
| Pubmed | 4.59e-05 | 725 | 32 | 6 | 27025967 | ||
| Pubmed | 4.80e-05 | 731 | 32 | 6 | 29298432 | ||
| Pubmed | 5.32e-05 | 1103 | 32 | 7 | 34189442 | ||
| Pubmed | WAVE1 is required for oligodendrocyte morphogenesis and normal CNS myelination. | 6.36e-05 | 13 | 32 | 2 | 16723544 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 6.59e-05 | 774 | 32 | 6 | 15302935 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 7.70e-05 | 486 | 32 | 5 | 30940648 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 1.08e-04 | 847 | 32 | 6 | 35235311 | |
| Pubmed | 1.11e-04 | 17 | 32 | 2 | 37072811 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 1.21e-04 | 1257 | 32 | 7 | 36526897 | |
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 1.29e-04 | 283 | 32 | 4 | 28533407 | |
| Pubmed | 1.36e-04 | 549 | 32 | 5 | 38280479 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 1.44e-04 | 1294 | 32 | 7 | 30804502 | |
| Pubmed | 1.46e-04 | 1297 | 32 | 7 | 33545068 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 1.62e-04 | 1318 | 32 | 7 | 30463901 | |
| Pubmed | 1.89e-04 | 121 | 32 | 3 | 34029587 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 2.17e-04 | 607 | 32 | 5 | 39147351 | |
| Pubmed | 2.31e-04 | 615 | 32 | 5 | 31048545 | ||
| Pubmed | 2.81e-04 | 1442 | 32 | 7 | 35575683 | ||
| Pubmed | 2.86e-04 | 1014 | 32 | 6 | 32416067 | ||
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 2.87e-04 | 349 | 32 | 4 | 25665578 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 3.02e-04 | 1024 | 32 | 6 | 24711643 | |
| Pubmed | 3.04e-04 | 653 | 32 | 5 | 22586326 | ||
| Pubmed | 3.08e-04 | 655 | 32 | 5 | 35819319 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 3.26e-04 | 361 | 32 | 4 | 26167880 | |
| Pubmed | 3.43e-04 | 1049 | 32 | 6 | 27880917 | ||
| Pubmed | 3.52e-04 | 1497 | 32 | 7 | 31527615 | ||
| Pubmed | Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. | 4.12e-04 | 384 | 32 | 4 | 31059266 | |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | 4.29e-04 | 704 | 32 | 5 | 32994395 | |
| Pubmed | 4.40e-04 | 708 | 32 | 5 | 39231216 | ||
| Pubmed | 4.52e-04 | 34 | 32 | 2 | 15146077 | ||
| Pubmed | 4.84e-04 | 723 | 32 | 5 | 34133714 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 4.87e-04 | 724 | 32 | 5 | 36232890 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | 5.12e-04 | 732 | 32 | 5 | 34732716 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 5.57e-04 | 1149 | 32 | 6 | 35446349 | |
| Pubmed | Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly. | 5.65e-04 | 38 | 32 | 2 | 36674791 | |
| Pubmed | 5.72e-04 | 419 | 32 | 4 | 15635413 | ||
| Pubmed | 5.82e-04 | 421 | 32 | 4 | 34650049 | ||
| Pubmed | 7.19e-04 | 191 | 32 | 3 | 20195357 | ||
| Pubmed | 8.28e-04 | 46 | 32 | 2 | 34767673 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 9.12e-04 | 475 | 32 | 4 | 31040226 | |
| Interaction | SMC5 interactions | EIF5B BAZ1B KRI1 BOD1L1 TAF3 LYAR LUC7L3 BAZ2B RSL1D1 PRRC2C NSRP1 ZMAT2 | 1.87e-08 | 1000 | 32 | 12 | int:SMC5 |
| Interaction | SRPK2 interactions | KRI1 UPF3B SELENOS LYAR LUC7L3 PNISR ZRSR2 RSL1D1 PRRC2C NSRP1 | 9.68e-08 | 717 | 32 | 10 | int:SRPK2 |
| Interaction | MAFB interactions | 2.16e-06 | 246 | 32 | 6 | int:MAFB | |
| Interaction | USP36 interactions | 3.25e-06 | 599 | 32 | 8 | int:USP36 | |
| Interaction | ZNF330 interactions | 5.17e-06 | 446 | 32 | 7 | int:ZNF330 | |
| Interaction | FBL interactions | 5.24e-06 | 639 | 32 | 8 | int:FBL | |
| Interaction | CIT interactions | EIF5B BAZ1B KRI1 TBC1D10B BOD1L1 UPF3B LYAR PDCD7 LUC7L3 RSL1D1 PRRC2C | 8.09e-06 | 1450 | 32 | 11 | int:CIT |
| Interaction | DDX23 interactions | 8.36e-06 | 480 | 32 | 7 | int:DDX23 | |
| Interaction | GTF2IRD1 interactions | 1.11e-05 | 88 | 32 | 4 | int:GTF2IRD1 | |
| Interaction | TNIP1 interactions | NUSAP1 EIF5B TBC1D10B UPF3B LYAR LUC7L3 RSL1D1 NSRP1 ZMAT2 PPP1R9A | 1.18e-05 | 1217 | 32 | 10 | int:TNIP1 |
| Interaction | POLD1 interactions | 1.31e-05 | 337 | 32 | 6 | int:POLD1 | |
| Interaction | NAA40 interactions | 1.47e-05 | 978 | 32 | 9 | int:NAA40 | |
| Interaction | PYHIN1 interactions | 1.85e-05 | 358 | 32 | 6 | int:PYHIN1 | |
| Interaction | MECP2 interactions | NUSAP1 EIF5B TBC1D10B TAF3 LYAR PDCD7 LUC7L3 PNISR ZRSR2 NSRP1 | 1.92e-05 | 1287 | 32 | 10 | int:MECP2 |
| Interaction | MYCN interactions | NUSAP1 EIF5B BAZ1B TBC1D10B UPF3B LYAR RSL1D1 PRRC2C NSRP1 ZMAT2 | 3.36e-05 | 1373 | 32 | 10 | int:MYCN |
| Interaction | NUP43 interactions | 4.57e-05 | 625 | 32 | 7 | int:NUP43 | |
| Interaction | KLF16 interactions | 4.83e-05 | 425 | 32 | 6 | int:KLF16 | |
| Interaction | ECT2 interactions | 5.59e-05 | 887 | 32 | 8 | int:ECT2 | |
| Interaction | ZCRB1 interactions | 5.82e-05 | 134 | 32 | 4 | int:ZCRB1 | |
| Interaction | FZR1 interactions | 6.12e-05 | 1172 | 32 | 9 | int:FZR1 | |
| Interaction | H3C1 interactions | 6.24e-05 | 901 | 32 | 8 | int:H3C1 | |
| Interaction | ZBTB2 interactions | 6.64e-05 | 450 | 32 | 6 | int:ZBTB2 | |
| Interaction | RAD18 interactions | 7.23e-05 | 457 | 32 | 6 | int:RAD18 | |
| Interaction | RC3H1 interactions | 7.57e-05 | 677 | 32 | 7 | int:RC3H1 | |
| Interaction | RPSA2 interactions | 9.49e-05 | 152 | 32 | 4 | int:RPSA2 | |
| Interaction | POLR1G interactions | 1.05e-04 | 489 | 32 | 6 | int:POLR1G | |
| Interaction | PDCD7 interactions | 1.11e-04 | 59 | 32 | 3 | int:PDCD7 | |
| Interaction | ZMAT5 interactions | 1.11e-04 | 59 | 32 | 3 | int:ZMAT5 | |
| Interaction | HECTD1 interactions | 1.16e-04 | 984 | 32 | 8 | int:HECTD1 | |
| Interaction | RRP1B interactions | 1.27e-04 | 314 | 32 | 5 | int:RRP1B | |
| Interaction | RPS24 interactions | 1.61e-04 | 529 | 32 | 6 | int:RPS24 | |
| Interaction | SRPK3 interactions | 2.24e-04 | 190 | 32 | 4 | int:SRPK3 | |
| Interaction | UTP23 interactions | 2.28e-04 | 191 | 32 | 4 | int:UTP23 | |
| Interaction | SRSF1 interactions | 2.41e-04 | 570 | 32 | 6 | int:SRSF1 | |
| Interaction | H2BC8 interactions | 2.55e-04 | 576 | 32 | 6 | int:H2BC8 | |
| Interaction | SOX2 interactions | 2.68e-04 | 1422 | 32 | 9 | int:SOX2 | |
| Interaction | LINC00240 interactions | 2.89e-04 | 16 | 32 | 2 | int:LINC00240 | |
| Interaction | CENPA interactions | 2.96e-04 | 377 | 32 | 5 | int:CENPA | |
| Interaction | JMJD6 interactions | 2.99e-04 | 205 | 32 | 4 | int:JMJD6 | |
| Interaction | DCAF4 interactions | 3.00e-04 | 378 | 32 | 5 | int:DCAF4 | |
| Interaction | PIP4K2A interactions | 3.65e-04 | 216 | 32 | 4 | int:PIP4K2A | |
| Interaction | RPS6 interactions | 3.66e-04 | 874 | 32 | 7 | int:RPS6 | |
| Interaction | KLF9 interactions | 4.28e-04 | 93 | 32 | 3 | int:KLF9 | |
| Interaction | NLE1 interactions | 4.47e-04 | 228 | 32 | 4 | int:NLE1 | |
| Interaction | NIFK interactions | 5.47e-04 | 431 | 32 | 5 | int:NIFK | |
| Interaction | RC3H2 interactions | 5.58e-04 | 667 | 32 | 6 | int:RC3H2 | |
| Interaction | DDRGK1 interactions | 5.87e-04 | 1249 | 32 | 8 | int:DDRGK1 | |
| Interaction | RPL31 interactions | 6.18e-04 | 680 | 32 | 6 | int:RPL31 | |
| Interaction | H2BC9 interactions | 6.38e-04 | 446 | 32 | 5 | int:H2BC9 | |
| Interaction | CHMP4C interactions | 6.52e-04 | 687 | 32 | 6 | int:CHMP4C | |
| Interaction | PRC1 interactions | 6.97e-04 | 973 | 32 | 7 | int:PRC1 | |
| Interaction | REXO4 interactions | 7.43e-04 | 261 | 32 | 4 | int:REXO4 | |
| Interaction | SNRNP70 interactions | 7.45e-04 | 984 | 32 | 7 | int:SNRNP70 | |
| Interaction | IFI16 interactions | 7.98e-04 | 714 | 32 | 6 | int:IFI16 | |
| Interaction | SRPK1 interactions | 8.64e-04 | 477 | 32 | 5 | int:SRPK1 | |
| Interaction | SNRPA interactions | 9.05e-04 | 482 | 32 | 5 | int:SNRPA | |
| Interaction | MEN1 interactions | 9.70e-04 | 1029 | 32 | 7 | int:MEN1 | |
| Interaction | SIRT7 interactions | 9.89e-04 | 744 | 32 | 6 | int:SIRT7 | |
| Interaction | TXNDC9 interactions | 9.90e-04 | 124 | 32 | 3 | int:TXNDC9 | |
| Interaction | BRD3 interactions | 1.01e-03 | 494 | 32 | 5 | int:BRD3 | |
| Interaction | H3C3 interactions | 1.02e-03 | 495 | 32 | 5 | int:H3C3 | |
| Interaction | NOP53 interactions | 1.07e-03 | 288 | 32 | 4 | int:NOP53 | |
| Interaction | CHD3 interactions | 1.08e-03 | 757 | 32 | 6 | int:CHD3 | |
| Interaction | ZNF845 interactions | 1.10e-03 | 31 | 32 | 2 | int:ZNF845 | |
| Interaction | KIF20A interactions | 1.10e-03 | 1052 | 32 | 7 | int:KIF20A | |
| Interaction | DHX8 interactions | 1.13e-03 | 292 | 32 | 4 | int:DHX8 | |
| Interaction | PRR11 interactions | 1.13e-03 | 130 | 32 | 3 | int:PRR11 | |
| Interaction | HMBOX1 interactions | 1.16e-03 | 131 | 32 | 3 | int:HMBOX1 | |
| Interaction | KAT6A interactions | 1.16e-03 | 510 | 32 | 5 | int:KAT6A | |
| Interaction | TRIM36 interactions | 1.52e-03 | 144 | 32 | 3 | int:TRIM36 | |
| Interaction | SART1 interactions | 1.53e-03 | 317 | 32 | 4 | int:SART1 | |
| Interaction | EFTUD2 interactions | 1.55e-03 | 1449 | 32 | 8 | int:EFTUD2 | |
| Interaction | HDGF interactions | 1.60e-03 | 321 | 32 | 4 | int:HDGF | |
| Interaction | DSCR9 interactions | 1.62e-03 | 147 | 32 | 3 | int:DSCR9 | |
| Interaction | BOD1L1 interactions | 1.68e-03 | 149 | 32 | 3 | int:BOD1L1 | |
| GeneFamily | PHD finger proteins | 3.29e-05 | 90 | 13 | 3 | 88 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 5.69e-05 | 16 | 13 | 2 | 14 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 9.12e-07 | 656 | 32 | 8 | M18979 | |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 4.84e-06 | 206 | 32 | 5 | M39254 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 9.99e-06 | 417 | 32 | 6 | M39224 | |
| Coexpression | KASLER_HDAC7_TARGETS_2_UP | 3.02e-05 | 7 | 32 | 2 | MM912 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 4.86e-05 | 166 | 32 | 4 | M8129 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | 5.30e-05 | 1144 | 32 | 8 | MM3843 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 6.37e-05 | 856 | 32 | 7 | M4500 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | 8.09e-05 | 1215 | 32 | 8 | M41122 | |
| Coexpression | GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN | 9.07e-05 | 195 | 32 | 4 | M7310 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_DN | 1.00e-04 | 200 | 32 | 4 | M7296 | |
| Coexpression | BASAKI_YBX1_TARGETS_DN | 1.13e-04 | 398 | 32 | 5 | M14877 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | 1.60e-04 | 429 | 32 | 5 | M29 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 1.81e-04 | 90 | 32 | 3 | M39250 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | 2.23e-04 | 1407 | 32 | 8 | M14427 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 2.36e-04 | 466 | 32 | 5 | M13522 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | 3.41e-04 | 790 | 32 | 6 | M12490 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 1.98e-10 | 186 | 31 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.20e-10 | 311 | 31 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CEP350 NUSAP1 EIF5B BAZ1B BOD1L1 UPF3B CCDC66 CEP126 LYAR LUC7L3 PNISR WASF1 RSL1D1 NSRP1 | 6.19e-10 | 1257 | 31 | 14 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | NUSAP1 EIF5B BAZ1B CEP126 LYAR PNISR ZRSR2 PRRC2C NSRP1 ZMAT2 | 7.35e-10 | 469 | 31 | 10 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CEP350 NUSAP1 EIF5B BAZ1B BOD1L1 UPF3B CCDC66 CEP126 LYAR LUC7L3 PNISR WASF1 RSL1D1 NSRP1 | 4.29e-09 | 1459 | 31 | 14 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.17e-07 | 595 | 31 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | NUSAP1 BAZ1B CCDC43 BOD1L1 UPF3B CCDC66 LYAR LUC7L3 PNISR NSRP1 | 1.68e-07 | 831 | 31 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.87e-07 | 629 | 31 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 3.87e-07 | 492 | 31 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | NUSAP1 EIF5B BAZ1B BOD1L1 UPF3B CCDC66 CEP126 LYAR LUC7L3 RSL1D1 NSRP1 | 7.43e-07 | 1241 | 31 | 11 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | NUSAP1 BAZ1B BOD1L1 TAF3 CCDC66 LYAR PDCD7 LUC7L3 RSL1D1 NSRP1 | 8.32e-07 | 989 | 31 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NUSAP1 BAZ1B BOD1L1 UPF3B CCDC66 LYAR LUC7L3 PNISR RSL1D1 NSRP1 | 8.32e-07 | 989 | 31 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | NUSAP1 BOD1L1 UPF3B CCDC66 CEP126 LYAR LUC7L3 WASF1 RSL1D1 WASF3 | 1.56e-06 | 1060 | 31 | 10 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.30e-06 | 271 | 31 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.37e-06 | 432 | 31 | 7 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | NUSAP1 EIF5B BAZ1B BOD1L1 UPF3B CCDC66 CEP126 LYAR LUC7L3 RSL1D1 NSRP1 | 3.86e-06 | 1468 | 31 | 11 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | NUSAP1 EIF5B BOD1L1 UPF3B TAF3 CCDC66 CEP126 LYAR LUC7L3 RSL1D1 | 6.94e-06 | 1252 | 31 | 10 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 7.24e-06 | 978 | 31 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.48e-05 | 375 | 31 | 6 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | NUSAP1 BOD1L1 UPF3B CCDC66 CEP126 LYAR LUC7L3 WASF1 RSL1D1 WASF3 | 2.02e-05 | 1414 | 31 | 10 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.53e-05 | 261 | 31 | 5 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | 1.05e-04 | 1371 | 31 | 9 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.43e-04 | 564 | 31 | 6 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.68e-04 | 192 | 31 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.68e-04 | 192 | 31 | 4 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.86e-04 | 1479 | 31 | 9 | PCBC_ratio_MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | 2.46e-04 | 893 | 31 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 3.18e-04 | 654 | 31 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.35e-04 | 230 | 31 | 4 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 4.33e-04 | 246 | 31 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.76e-04 | 277 | 31 | 4 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 7.14e-04 | 498 | 31 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | 7.76e-04 | 774 | 31 | 6 | gudmap_developingKidney_e15.5_cortic collect duct_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 8.08e-04 | 780 | 31 | 6 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 8.12e-04 | 291 | 31 | 4 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 8.87e-04 | 298 | 31 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 9.60e-04 | 532 | 31 | 5 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.14e-03 | 834 | 31 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | 1.20e-03 | 1164 | 31 | 7 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.43e-03 | 339 | 31 | 4 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.78e-03 | 1245 | 31 | 7 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_200 | 1.80e-03 | 166 | 31 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.02e-03 | 173 | 31 | 3 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k1 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | CEP350 EIF5B KRI1 BOD1L1 UPF3B TAF3 LYAR LUC7L3 PNISR ZRSR2 PRRC2C NSRP1 | 7.40e-21 | 197 | 32 | 12 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 7.10e-11 | 192 | 32 | 7 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 9.13e-11 | 199 | 32 | 7 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 9.13e-11 | 199 | 32 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 9.13e-11 | 199 | 32 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.59e-07 | 194 | 32 | 5 | 8985095f291c1b54e45f4edece49aa26e8c8b732 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.87e-07 | 198 | 32 | 5 | 1847ce8c344c8a3e50f3cbbf758a38aba69f85b0 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 2.94e-07 | 199 | 32 | 5 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 2.94e-07 | 199 | 32 | 5 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.94e-07 | 199 | 32 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | normal-na-Lymphocytic_T-T8_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.90e-06 | 184 | 32 | 4 | 4a81190b36d197736663e6177d3b76c1cb6282d6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 9.89e-06 | 189 | 32 | 4 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 191 | 32 | 4 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 191 | 32 | 4 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 191 | 32 | 4 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.07e-05 | 193 | 32 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-05 | 194 | 32 | 4 | 6cf9d59aec8dd18fa2fc1652ddd0f5ef1f24bcb6 | |
| ToppCell | normal-na-Lymphocytic_T-T4_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.14e-05 | 196 | 32 | 4 | feb1c768cf66c64b6c892905d2d865946e70812f | |
| ToppCell | Control-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.16e-05 | 197 | 32 | 4 | 925bf0d38e4ce279fa45f455546ebd199282c0df | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.19e-05 | 198 | 32 | 4 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 199 | 32 | 4 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.21e-05 | 199 | 32 | 4 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.21e-05 | 199 | 32 | 4 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.24e-05 | 200 | 32 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.71e-04 | 151 | 32 | 3 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|normal_Lung / Location, Cell class and cell subclass | 2.26e-04 | 166 | 32 | 3 | ff32422390852546e0cb216192452e9c47bd9509 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-4|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.26e-04 | 166 | 32 | 3 | 52293b8a74d46e6161fb6a2e7e86e51fd9e89a5b | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.64e-04 | 175 | 32 | 3 | 6374ab186d7ccf7f6dfb858267edba8962789e15 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 184 | 32 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 3.11e-04 | 185 | 32 | 3 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 187 | 32 | 3 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.21e-04 | 187 | 32 | 3 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.26e-04 | 188 | 32 | 3 | 0476d7ee3e0ce78c3c5b111e9ade01098f9ea7ec | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 188 | 32 | 3 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.31e-04 | 189 | 32 | 3 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.41e-04 | 191 | 32 | 3 | b6cc0a9ced40ce5f80065d24d5bc20e3838a7682 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.46e-04 | 192 | 32 | 3 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 193 | 32 | 3 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 193 | 32 | 3 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 193 | 32 | 3 | 49f4fbec91acda4727703e0e359ed780eefb8a22 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 193 | 32 | 3 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.52e-04 | 193 | 32 | 3 | 4e78ddc96d8e403a21c4a303b1f26512d2ac91e8 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 193 | 32 | 3 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.57e-04 | 194 | 32 | 3 | b111d10c99d7ff7eb261cd7786cd9d9a549049b1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.57e-04 | 194 | 32 | 3 | 40c6e17e9e48d4fa6da3a0a1066c4c6565a1e096 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.62e-04 | 195 | 32 | 3 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 3.62e-04 | 195 | 32 | 3 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.62e-04 | 195 | 32 | 3 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 195 | 32 | 3 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.68e-04 | 196 | 32 | 3 | 5ed7f063fc4ba213fe15256caf77f59c9e476290 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 3.68e-04 | 196 | 32 | 3 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 3.73e-04 | 197 | 32 | 3 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.73e-04 | 197 | 32 | 3 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | moderate-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.79e-04 | 198 | 32 | 3 | 0a868098b1ee4b28b2149ed766acb09e9c0ce14c | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.79e-04 | 198 | 32 | 3 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 3.79e-04 | 198 | 32 | 3 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.85e-04 | 199 | 32 | 3 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | lymphoid|World / Lineage, cell class and subclass | 3.85e-04 | 199 | 32 | 3 | bf599721e7109cf9f361e9381544c291920c28be | |
| ToppCell | severe-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.90e-04 | 200 | 32 | 3 | 61c7c08460856c188e62edf1fa62855578146fc8 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 3.90e-04 | 200 | 32 | 3 | e16bde12326f0cfc4d03f9307cba0e21ea2389cb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.90e-04 | 200 | 32 | 3 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-CD8+_Tcm|Multiple_Sclerosis / Disease, condition lineage and cell class | 3.90e-04 | 200 | 32 | 3 | d9d888842d84a2b70173896d81ca183fa53c814c | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 3.90e-04 | 200 | 32 | 3 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 3.90e-04 | 200 | 32 | 3 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-04 | 200 | 32 | 3 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | H1299|World / Cell line, Condition and Strain | 3.90e-04 | 200 | 32 | 3 | 23f08d7cffacfced48785cd3ad230ecadb95713f | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.35e-08 | 49 | 20 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.02e-04 | 50 | 20 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Drug | Clorgyline | 3.00e-06 | 168 | 31 | 5 | ctd:D003010 | |
| Disease | Precancerous Conditions | 5.60e-03 | 110 | 30 | 2 | C0032927 | |
| Disease | Condition, Preneoplastic | 5.60e-03 | 110 | 30 | 2 | C0282313 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EENDKKRAEKQKRKE | 786 | Q9UIG0 | |
| RKKAEEKERLKQEKR | 1021 | Q9UIF8 | |
| KQEKRDEKRLNKERK | 1031 | Q9UIF8 | |
| KEQEKRMEKKIQRER | 116 | Q9H0G5 | |
| KQERKEKEKKRTQRG | 206 | Q96MW1 | |
| QEEERKRELEKKQRK | 381 | Q8N8D1 | |
| RLKKEKQEREEREKE | 246 | O95232 | |
| RERKKREKAKKQEEL | 336 | Q8N9T8 | |
| KEEQRKKREQERKEK | 411 | Q9BXS6 | |
| EEQRIKEERKKQKEE | 341 | Q96JM4 | |
| KEERKKQKEEERKRR | 346 | Q96JM4 | |
| EERRKWKEEEKRKRK | 231 | Q9BZI7 | |
| NREKLEEKRKQKAEK | 511 | Q8NFC6 | |
| RKKAFEEKRKEQEEK | 81 | Q9P2H0 | |
| EEKRRKKQLEEEQRK | 476 | A2RUB6 | |
| ERKRKQNEEKKAQKE | 606 | Q5VT06 | |
| QGEVKKNKRERKEER | 181 | Q9NX58 | |
| ERKRTKKKKEQGQER | 231 | Q9NPI7 | |
| TKMKKKEKQRDRERE | 531 | Q5VWG9 | |
| KEKQRDREREKDKNK | 536 | Q5VWG9 | |
| KEREKEKREREKREK | 721 | Q5VWG9 | |
| EKREREKREKEKEKH | 726 | Q5VWG9 | |
| KRKKKEEAARRKQEQ | 661 | P49589 | |
| RLEQEKRERKKQKEK | 381 | O60841 | |
| RKREREKEEKNEKEL | 71 | Q7Z5D8 | |
| EKERKQEKEKELERQ | 556 | Q9Y520 | |
| REEEKRRKKEEKRKE | 201 | Q9H6E4 | |
| KEKLKQLEEEKRRQK | 101 | Q9BQE4 | |
| RRERNFEKQKERKKK | 291 | O76021 | |
| DKRKEKRRQKEQKRI | 171 | Q9UPY6 | |
| TRKQEKERQKQEKER | 721 | Q4KMP7 | |
| KERQKQEKERQKQEK | 726 | Q4KMP7 | |
| EREKERQKQEKEREK | 741 | Q4KMP7 | |
| RQKQEKEREKQEKER | 746 | Q4KMP7 | |
| KEREKQEKEREKQEK | 751 | Q4KMP7 | |
| DRKKKDKEREREQDK | 676 | Q8TF01 | |
| DKEREREQDKRKEKQ | 681 | Q8TF01 | |
| REQDKRKEKQKREEK | 686 | Q8TF01 | |
| LQDTEDKRKEKRKQK | 166 | Q92558 | |
| FKENNRRRKKERKEK | 716 | Q8IWU6 | |
| RKEREEEEQKRQEKK | 116 | Q15696 | |
| KEKQKEKKRRAEEDL | 161 | Q96NC0 | |
| KMEKQREKLRRKEQE | 1061 | Q9ULJ8 |